While other groups have demonstrated that microglia ablation in animal models of Alzheimer’s disease reduces the signs of disease [27–29], we have demonstrated that reducing microglia in the CNS of mice using the CSF-1R inhibitor PLX5622 accelerates prion disease [22]. Here, CSF1R is linked to prion disease.